Cancer cells transfer mitochondria through nanotubes to healthy neighboring cells, turning them into tumor-supporting accomplices, a new study shows.

The U.S. Food and Drug Administration has granted accelerated approval to Forzinity (elamipretide) injection as the first ...

Explore what FDA approval of elamipretide means for ultra-rare disease drug development and the outlook for future biotech ...

Researchers have reconstructed transcription in human mitochondria in unprecedented detail, revealing potential drug targets ...

Stealth BioTherapeutics has claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome, ...

First-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that ...

Microplastics present in household dust and water damage mitochondria, accelerating aging and increasing the risk of disease.

New findings on enzyme dynamics could guide new therapies for mitochondrial diseases.

Professor Adam Paré's research identifies the fundamental mechanisms that mold tissues during animal development. On Wednesday, he will discuss epithelial remodeling during development.

Aging, neurological diseases and our bodies' stress response are all linked to the tiny power plants inside each cell known ...

A decade-long journey has come to an end for Stealth BioTherapeutics and the Barth syndrome community with the first-ever ...